TargetAlpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase(Homo sapiens (Human))
AbbVie Inc.; AbbVie Deutschland GmbH & Co. KG
US Patent
AbbVie Inc.; AbbVie Deutschland GmbH & Co. KG
US Patent
Affinity DataKi: <1.00E+4nMAssay Description:Radioligand binding assays using recombinant CHO cell membranes expressing human GlyT1: Radioligand binding to human GlyT1c transporter-expressing me...More data for this Ligand-Target Pair